CDX2, TTF1, and GATA-3 Profiles of the Tumors and Chromogranin A, Synaptophysin, and CD56 Staining Status of Neuroendocrine Neoplasms According to Their Origin. This evidence concerns the gene CHGA and neuroendocrine neoplasm.